Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Benitec Biopharma Ltd (NASDAQ:BNTC)

2.61
Delayed Data
As of Oct 18
 -0.16 / -5.78%
Today’s Change
1.30
Today|||52-Week Range
5.48
+70.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$28.4M

Company Description

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia.

Contact Information

Benitec Biopharma Ltd.
F6A/1-15 Barr Street
Sydney New South Wales (nsw) 2041
P:(129) 555-6986
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gregory C. WestChief Executive Officer & Secretary
Cliff HollowayChief Operating & Business Officer
Bryan DulhuntyChief Financial Officer
David SuhyChief Scientific Officer
Georgina H. KilfoilChief Clinical & Development Operations Officer